Magdalena Latosińska

Ms. Magdalena Latosińska

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2014 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
JLJolanta Natalia Latosińska
Jolanta Natalia Latosińska
MLMagdalena Latosińska
Magdalena Latosińska
GOGrzegorz A. Olejniczak
Grzegorz A. Olejniczak
JSJanez Seliger
Janez Seliger
VŽVeselko Žagar
Veselko Žagar
Three anhydrous methylxanthines: caffeine (1,3,7-trimethylxanthine; 1,3,7-trimethyl-1H-purine-2,6-(3H,7H)-dione) and its two metabolites theophylline (1,3-dimethylxanthine; 1,3-dimethyl-7H-purine-2,6-dione) and theobromine (3,7-dimethyl-xanthine; 3,7-dimethyl-7H-purine-2,6-dione), which reveal multifaceted therapeutic potential, have been studied experimentally in solid state by 1H–14N NMR-NQR (nuclear magnetic resonance–nuclear quadrupole resonance) double resonance (NQDR). For each compound the complete NQR spectrum consisting of 12 lines was recorded. The multiplicity of NQR lines indicates the presence of a stable β form of anhydrous caffeine at 233 K and stable form II of anhydrous theobromine at 213 K. The assignment of signals detected in NQR experiment to particular nitrogen atoms was made on the basis of quantum chemistry calculations performed for monomer, cluster, and solid at the DFT/GGA/BLYP/DPD level. The shifts due to crystal packing interactions were evaluated, and the multiplets detected by NQR were assigned to N(9) in theobromine and N(1) and N(9) in caffeine. The ordering theobromine > theophylline > caffeine site and theophylline < theobromine < caffeine according to increasing electric field gradient (EFG) at the N(1) and N(7) sites, respectively, reflects the changes in biological activity profile of compounds from the methylxanthines series (different pharmacological effects). This difference is elucidated on the basis of the ability to form intra- and intermolecular interactions (hydrogen bonds and π···π stacking interactions). The introduction of methyl groups to xanthine restricts the ability of nitrogen atoms to participate in strong hydrogen bonds; as a result, the dominating effect shifts from hydrogen bond (theobromine) to π···π stacking (caffeine). Substantial differences in the intermolecular interactions in stable forms of methylxanthines differing in methylation (site or number) were analyzed within the Hirshfeld surface-based approach. The analysis of local environment of the nitrogen nucleus permitted drawing some conclusions on the nature of the interactions required for effective processes of recognition and binding of a given methylxanthine to A1–A2A receptor (target for caffeine in the brain). Although the interactions responsible for linking neighboring methylxanthines molecules in crystals and methylxanthines with targets in the human organism can differ significantly, the knowledge of the topology of interactions provides reliable preliminary information about the nature of this binding.

1 December 2009 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
JLJolanta Natalia Latosińska
Jolanta Natalia Latosińska
MLMagdalena Latosińska
Magdalena Latosińska
JSJ. Seliger
J. Seliger
VŽV. Žagar
V. Žagar
JMJan Krzysztof Maurin
Jan Krzysztof Maurin
ZKZ. Kazimierczuk
Z. Kazimierczuk

5 March 2014 in The Journal of Physical Chemistry A
Verified
Journal Article
Open access
JLJolanta Natalia Latosińska
Jolanta Natalia Latosińska
MLMagdalena Latosińska
Magdalena Latosińska
JMJan Krzysztof Maurin
Jan Krzysztof Maurin
AOAndrzej Orzeszko
Andrzej Orzeszko
ZKZygmunt Kazimierczuk
Zygmunt Kazimierczuk
The weak interaction patterns in 4,5,6,7-tetrahalogeno-1H-benzimidazoles, protein kinase CK2 inhibitors, in solid state are studied by the X-ray method and quantum chemistry calculations. The crystal structures of 4,5,6,7-tetrachloro- and 4,5,6,7-tetrabromo-1H-benzimidazole are determined by X-ray diffraction and refined to a final R-factor of 3.07 and 3.03%, respectively, at room temperature. The compound 4,5,6,7-tetrabromo-1H-benzimidazole, which crystallizes in the I41/a space group, is found to be isostructural with previously studied 4,5,6,7-tetraiodo-1H-benzimidazole in contrast to 4,5,6,7-tetrachloro-1H-benzimidazole, which crystallizes as triclinic P1̅ with 4 molecules in elementary unit. For 4,5,6,7-tetrachloro-1H-benzimidazole, differential scanning calorimetry (DSC) revealed a second order glassy phase transition at Tg = 95°/106° (heating/cooling), an indication of frozen disorder. The lack of 3D isostructurality found in all 4,5,6,7-tetrahalogeno-1H-benzimidazoles is elucidated on the basis of the intra- and intermolecular interactions (hydrogen bonding, van der Waals contacts, and C–H···π interactions). The topological Bader’s Quantum Theory of Atoms in Molecules (QTAIM) and Spackman’s Hirshfeld surface-based approaches reveal equilibration of electrostatic matching and dispersion van der Waals interactions between molecules consistent with the crystal site-symmetry. The weakening of van der Waals forces accompanied by increasing strength of the hydrogen bond (N–H···N) result in a decrease in the crystal site-symmetry and a change in molecular packing in the crystalline state. Crystal packing motifs were investigated with the aid of Hirshfeld surface fingerprint plots. The ordering 4,5,6,7-tetraiodo > 4,5,6,7-tetrabromo > 4,5,6,7-tetrachloro > 4,5,6,7-tetrafluoro reflects not only a decrease in crystal symmetry but also increase in chemical reactivity (electronic activation), which could explain some changes in biological activity of compounds from the 4,5,6,7-tetrahalogeno-1H-benzimidazole series. The ability of formation of a given type of bonds by 4,5,6,7-tetrahalogeno-1H-benzimidazole molecules is the same in the crystal and in CK2. Analysis of the interactions in the crystal permits drawing conclusions on the character (the way) of connections between a given 4,5,6,7-tetrahalogeno-1H-benzimidazole as a ligand with CK2 protein to make a protein–ligand complex.

11 May 2015 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
JLJolanta Natalia Latosińska
Jolanta Natalia Latosińska
MLMagdalena Latosińska
Magdalena Latosińska
MTMarzena Agnieszka Tomczak
Marzena Agnieszka Tomczak
WMWojciech Medycki
Wojciech Medycki

22 January 2003 in Journal of Molecular Structure
Verified
Journal Article
Closed access
JLJolanta Natalia Latosińska
Jolanta Natalia Latosińska
MLMagdalena Latosińska
Magdalena Latosińska
JKJ Koput
J Koput

13 August 2014 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
JLJolanta Natalia Latosińska
Jolanta Natalia Latosińska
MLMagdalena Latosińska
Magdalena Latosińska
JSJanez Seliger
Janez Seliger
VŽVeselko Žagar
Veselko Žagar
ZKZygmunt Kazimierczuk
Zygmunt Kazimierczuk